Total glucosides of paeony (TGP) alleviates constipation and intestinal inflammation in mice induced by Sjögren's syndrome
- 7 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 260, 113056
- https://doi.org/10.1016/j.jep.2020.113056
Abstract
No abstract availableKeywords
Funding Information
- China Pharmaceutical University
This publication has 41 references indexed in Scilit:
- An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjogren's syndromeInternational Immunology, 2011
- VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studiesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Treatment of Primary Sjögren SyndromeJAMA, 2010
- Pathogenesis of Sjögren's syndromeCurrent Opinion in Rheumatology, 2009
- Vasoactive intestinal peptide inhibits TNF-α-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glandsArthritis Research & Therapy, 2009
- Bowel symptoms in patients with primary Sjögren's syndromeScandinavian Journal of Rheumatology, 2007
- Kit mutants and gastrointestinal physiologyJournal Of Physiology-London, 2006
- Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndromeAnnals Of The Rheumatic Diseases, 2006
- Vasoactive intestinal peptide (VIP) inhibits TGF-β1 production in murine macrophagesJournal of Neuroimmunology, 2000
- Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipationDigestive Diseases and Sciences, 1995